Recent Finacing
Recent Raise
Sotio Biotech is a clinical-stage immuno-oncology company in Prague developing IL-15–based therapies, including SOT101 (IL-15 superagonist in phase 2), BOXR1030 CAR‑T, and SOT102 ADC.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Sotio.
